SOUTH SAN FRANCISCO, CA--(MARKET WIRE)--Jun 6, 2007 -- CoMentis, Inc. (formerly Athenagen), a privately held biopharmaceutical company, announced today that Martin Tolar, M.D., Ph.D., has joined the company as Vice President of Strategic and Corporate Development, a newly created position. Dr. Tolar joins CoMentis from Pfizer, where he spent six years in a variety of leadership positions in Clinical Development and Alliance Management, as well as Business Development. Most recently, Dr. Tolar chaired the Neuroscience Licensing Team at Pfizer.
